ClinicalTrials.Veeva

Menu

AirSonea Wheeze Detection Study

I

iSonea

Status

Unknown

Conditions

Asthma
COPD

Treatments

Device: AirSonea

Study type

Interventional

Funder types

Industry

Identifiers

NCT01927172
iS-2013-Wz

Details and patient eligibility

About

The purpose of this study is to determine if the AirSonea device provides an objective assessment of breath sounds for the presence of wheeze in both medical and home environments.

Enrollment

85 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Part I: Participants presenting to an Acute Care Setting with an exacerbation of asthma or chronic obstructive pulmonary disease symptoms

  • Part II: Volunteer participants without asthma

  • Part III: Participants with asthma

  • For all parts of study

    • Age: 18 years or older
    • Participant has signed an Informed Consent after having the Study explained to them.

Exclusion criteria

  • Any medical finding by the physician that would exclude the patient from participating.
  • < than 18 years of age

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

85 participants in 1 patient group

AirSonea
Other group
Description:
Use of AirSonea to detect wheeze sounds.
Treatment:
Device: AirSonea

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems